image
Healthcare - Biotechnology - NASDAQ - US
$ 2.195
-0.971 %
$ 346 M
Market Cap
4.25
P/E
Price Target Average
59.34%
Revenue Forecast Estimate
--5.67%
EBIT Estimate
--35.54%
Net Income Estimate
--16.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets CytomX Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for CTMX of $3.5 , with forecasts ranging from a low of $3.25 to a high of $3.68 .
CTMX Lowest Price Target Wall Street Target
3.25 USD 48.06%
CTMX Average Price Target Wall Street Target
3.5 USD 59.34%
CTMX Highest Price Target Wall Street Target
3.68 USD 67.65%
Price
Max Price Target
Min Price Target
Average Price Target
444433332222111100Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26May '26May '26
REVENUE FORECAST

Revenue Forecast Chart CTMX

image
$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CTMX

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CTMX

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029